Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 4 , Pages 377-388, July 2010

p53 immunohistochemistry in bladder cancer—a new approach to an old question

  • Peter J. Goebell, M.D.

      Affiliations

    • Department of Urology, Friedrich-Alexander University Erlangen, Erlangen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 (0) 9131-822-3122; fax: +49 (0) 9131-822-3179
  • ,
  • Susan G. Groshen, Ph.D.

      Affiliations

    • Department of Preventive Medicine and Biostatistics, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA 90089, USA
  • ,
  • Bernd J. Schmitz-Dräger, M.D., Ph.D.

      Affiliations

    • Department of Urology, Euromed Clinic, Fürth, Germany
  • ,
  • International Study-Initiative on Bladder Cancer (ISBC)

      Affiliations

    • The members of the ISBC and participants of this trial are: Bernd J. Schmitz-Dräger, Fürth, Peter J. Goebell, Erlangen, Guido Sauter, Hamburg, Germany, Thomas C. Gasser, Basel, Switzerland, Yves Fradet, Quebec, Canada, Helene LaRue, Quebec, Canada, Pertti K. Lipponen, Kuopio, Finland, Tapani JO Liukkonen, Mikkeli, Finland, Pertti Rajala, Mikkeli, Finland, M′Liss Ann Hudson, Washington, USA, Peter A. Humphrey, Washington, USA, Giovanni Casetta, Torino, Italy, Alessandro Tizziani, Torino, Italy, Stefan Wellek, Mannheim, Germany, Michael Stöckle, Homburg, Germany, Staffan Jahnson, Örebrö, Sweden, Björn Risberg, Oslo, Norway, Pier Francesco Bassi, Rome, Italy, Anna Rosa Del Mistro, Padova, Italy, T.R. Leyshon Griffiths, Leicester, UK, David E. Neal, Cambridge, UK, Mutsuo Furihata, Kochi, Nankoku, Japan, Dominique Chopin, Creteil, France, Zivko Popov, Creteil, France, Alan Pollack, Houston, USA, Gunar Zagars, Houston, USA, Paolo Dalla Palma, Trento, Italy, Lucio Luciani, Trento, Italy, Lydia Nakopoulou, Athens, Greece, Robert A. Gardiner, Herson, Australia, Mark A. Underwood, Glasgow, UK, Yoshiyuki Kakehi, Kagawa, Japan, Toyoaki Uchida, Kitasato, Japan, Jack Schalken, Nijmegen, The Netherlands, Alexandre R. Zlotta, Toronto, Canada, H. Barton Grossman, Houston, USA, George N. Thalman, Bern, Switzerland, David J. Thomas, Leeds, UK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This trial was performed under the auspices of the International Bladder Cancer Network (IBCN).

PII: S1078-1439(10)00108-0

doi:10.1016/j.urolonc.2010.03.021

Urologic Oncology: Seminars and Original Investigations
Volume 28, Issue 4 , Pages 377-388, July 2010